INTERNATIONAL PATENT: GENZYME CORPORATION FILES APPLICATION FOR "LIPID NANOPARTICLES TARGETING CENTRAL NERVOUS SYSTEM ENDOTHELIAL CELLS"

GENEVA, May 12 -- GENZYME CORPORATION (450 Water StreetCambridge, MA 02141) filed a patent application (PCT/US2025/053440) for "LIPID NANOPARTICLES TARGETING CENTRAL NERVOUS SYSTEM ENDOTHELIAL CELLS" on Oct 31, 2025. With publication no. WO/2026/096836, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BANDEKAR, Amey (C/o Genzyme Corporation450 Water StreetCambridge, MA 02141), GOULET, Martin (C/o Genzyme Corporation450 Water StreetCambridge, MA 02141), FLEMING, Michael, Scott (C/o Genzyme Corporation450 Water StreetCambrid...